BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,130,000 | -31.3% | 82,959 | +0.4% | 0.00% | -50.0% |
| Q3 2016 | $1,644,000 | +53.2% | 82,628 | -0.2% | 0.00% | +100.0% |
| Q2 2016 | $1,073,000 | +284.6% | 82,773 | +177.7% | 0.00% | – |
| Q1 2016 | $279,000 | -53.0% | 29,811 | +1.8% | 0.00% | -100.0% |
| Q4 2015 | $594,000 | +42.4% | 29,287 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $417,000 | -34.9% | 28,730 | -4.7% | 0.00% | 0.0% |
| Q2 2015 | $641,000 | +11.1% | 30,149 | +21.1% | 0.00% | 0.0% |
| Q1 2015 | $577,000 | – | 24,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |